CARA Stock Continues to Rise: Reasons to Watch This BioTech Stock
A biotechnology company firmly on the radar is Cara Therapeutics (NASDAQ:CARA). The US-based drug developer was recently successful in its trialing of lead candidate Korsuva. At the end of May, CARA stock popped as the ... [Read]
Cara Therapeutics Stock Increases After Revealing Promising Data From a Phase 1 Drug Trial
On Wednesday, Cara Therapeutics (NASDAQ:$CARA) stock increased after the biotech company revealed promising data from a Phase 1 drug trial for chronic kidney disease patients. If you’re a biotech investor, you are probably aware of ... [Read]
What You Should Know Before Investing in Cannabis
According to the 2016 Marijuana Business Factbook, written by Marijuana Business Daily, if current trends of marijuana continues for the next couple years, by 2020 the cannabis industry has the potential to provide up to ... [Read]